Literature DB >> 11982752

Stromelysin-1 activation correlates with invasiveness in squamous cell carcinoma.

Tiziana De Angelis1, Adele Noè, Mitali Chatterjee, Joy Mulholland.   

Abstract

The expression of selected metalloproteinases and tissue inhibitors of metalloproteinases (TIMP) was examined in three squamous cell carcinoma (SCC) cell lines (FaDu, SiHa, A431) and a keratinocyte cell line (HaCaT) to determine which metalloproteinases function in SCC invasiveness. A Matrigel invasion assay was used to assess invasiveness of the cell lines. Only the FaDu cell line showed invasiveness in this assay, and invasion of Matrigel by FaDu cells was inhibited by treatment with the metalloproteinase inhibitor, batimastat. No correlation was found between mRNA expression for matrilysin, stromelysins 1-3, TIMP-1, or TIMP-3 and secretion of these proteins, indicating that the extracellular activity of these molecules is regulated post-transcriptionally. The SCC cell lines differed from the HaCaT line in that matrilysin and TIMP-1 proteins were detected in conditioned medium from all SCC cell lines, but not in medium from HaCaT cells. Only the invasive cell line, FaDu, released active stromelysin-1 into the culture medium. These results indicate that while matrilysin contributes to the invasive phenotype, activation of stromelysin-1 is a key regulatory step for invasiveness in SCC cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982752     DOI: 10.1046/j.1523-1747.2002.01755.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Rap1 stabilizes beta-catenin and enhances beta-catenin-dependent transcription and invasion in squamous cell carcinoma of the head and neck.

Authors:  Mitsuo Goto; Raj S Mitra; Min Liu; Julia Lee; Bradley S Henson; Thomas Carey; Carol Bradford; Mark Prince; Cun-Yu Wang; Eric R Fearon; Nisha J D'Silva
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

2.  Induction of ΔNp63 by the newly identified keratinocyte-specific transforming growth factor β Signaling Pathway with Smad2 and IκB Kinase α in squamous cell carcinoma.

Authors:  Nahoko Fukunishi; Iyoko Katoh; Yoshiya Tomimori; Keiichi Tsukinoki; Ryu-Ichiro Hata; Atsuhito Nakao; Yoji Ikawa; Shun-Ichi Kurata
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

3.  Differential expression of stromal MMP-1, MMP-9 and TIMP-1 in basal cell carcinomas of immunosuppressed patients and controls.

Authors:  Sonja Boyd; Kalle Tolvanen; Susanna Virolainen; Tiina Kuivanen; Lauri Kyllönen; Ulpu Saarialho-Kere
Journal:  Virchows Arch       Date:  2007-11-22       Impact factor: 4.064

4.  Comparative studies on the secretion and activation of MMPs in two reconstructed human skin models using HaCaT- and HaCaT-ras-transfected cell lines.

Authors:  D Nova; C Le Griel; S Holvoet; E Gentilhomme; C Vincent; M J Staquet; D Schmitt; M Serres
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

5.  CCHCR1 is up-regulated in skin cancer and associated with EGFR expression.

Authors:  Sari Suomela; Outi Elomaa; Tiina Skoog; Risto Ala-aho; Leila Jeskanen; Jenita Pärssinen; Leena Latonen; Reidar Grénman; Juha Kere; Veli-Matti Kähäri; Ulpu Saarialho-Kere
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

6.  Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysis.

Authors:  Nicolae-Costin Diaconu; Jaana Rummukainen; Mikko Mättö; Anita Naukkarinen; Rauno J Harvima; Jukka Pelkonen; Ilkka T Harvima
Journal:  BMC Cancer       Date:  2008-02-07       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.